MAZE
MAZE
NASDAQ · Pharmaceuticals

Maze Therapeutics Inc

$25.68
+0.84 (+3.38%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +265.7% upside
Low Target $74.59
Average Target $93.90
High Target $145.81
Current Price $25.68
Current
$25.68
Target
$93.90
$74.59 $93.90 avg $145.81
Scenario Analysis
Bear Case
$74.59
190.5%
Low target
Base Case
$93.90
+265.7%
Avg target
Bull Case
$145.81
+467.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$53.65
-52.1% from high
52-Week Low
$9.83
+161.2% from low
50-Day SMA
$42.71
-39.9% vs SMA
200-Day SMA
$25.83
-0.6% vs SMA
RSI (14)
50.1
Neutral
Target vs 52W High
$93.90
+75.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%